-
Featured
Stem Cells and COVID-19
Bone-marrow derived stem cells have been proposed as potential therapies for a wide variety of ailments, from rotator cuff injury to Alzheimer’s disease.
-
Co-transplantation of Regulatory T Cells Improves Cell Replacement Therapy for Parkinson's Disease
Research at Massachusetts General Hospital suggests a novel strategy for enhancing the efficacy and safety of cell replacement therapy in the nervous system: co-transplantation of dopamine progenitor cells with regulatory T cells to modulate the host immune response triggered by needle trauma.
-
The Future of Neurosurgery and Neuroscience at Mass General: Q&A With Bob S. Carter, MD, PhD
Bob S. Carter, MD, PhD, is the chief of the Department of Neurosurgery at Massachusetts General Hospital. In this Q&A, Dr. Carter elaborates on intraoperative molecular diagnostics. Dr. Carter is also a 2021 Congress of Neurological Surgeons (CNS) honored guest.
-
P-Bodies Linked to Cell-Fate Transitions in Stem Cells
Konrad Hochedlinger, PhD, of the Massachusetts General Hospital Cancer Center, and colleagues have shown for the first time that dissolution of P-bodies in embryonic stem cells and adult progenitors releases key fate-instructive mRNAs to drive cellular differentiation.
-
Advances in Palliative Care and the CORE Program at Mass General Cancer Center
Areej El-Jawahri, MD, explains the Massachusetts General Hospital Cancer Outcomes Research and Education Program (CORE) and discusses the advances in palliative care at Mass General Cancer Center.
-
Palliative Care Benefits Patients Undergoing Stem Cell Transplantation
Massachusetts General Hospital researchers have found that even apart from medication for symptom control, palliative care has benefits for patients facing the prolonged hospitalization required for hemopoietic stem cell transplantation.
Stem Cell Therapy Contributors
-
Areej R. El-Jawahri, MD
Hematologist, Mass General Cancer Center, Assistant in Medicine, Massachusetts General Hospital, Instructor in Medicine, Harvard Medical School
Recent Article
Enasidenib Safe, Well Tolerated As Maintenance After Stem Cell Transplantation for IDH2-Mutated Myeloid Malignancies
-
Bob S. Carter, MD, PhD
Chief, Neurosurgery Service
Recent Article
Co-transplantation of Regulatory T Cells Improves Cell Replacement Therapy for Parkinson's Disease
-
Jamie M. Jacobs, PhD
Program Director, Center for Psychiatric Oncology and Behavioral Sciences, Director of Caregiving Research, Cancer Outcomes Research Program, Mass General Cancer Center, Assistant Professor of Psychology in the Department of Psychiatry, Harvard Medical School
Recent Article
Intervening to Reduce Cancer Caregiver Stress
-
Jeffrey S. Schweitzer, MD, PhD
Neurosurgeon
Recent Article
Co-transplantation of Regulatory T Cells Improves Cell Replacement Therapy for Parkinson's Disease
-
Todd M. Herrington, MD, PhD
Director, Deep Brain Stimulation Program, Massachusetts General Hospital
Recent Article
Co-transplantation of Regulatory T Cells Improves Cell Replacement Therapy for Parkinson's Disease
-
Ziv Williams, MD
Neurosurgeon, Department of Neurosurgery, Massachusetts General Hospital, Associate Professor in Neurosurgery, Harvard Medical School
Recent Article
Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.